Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Sareum Share Price
  4. Sareum Share Regulatory News
  5. Director/PDMR Shareholding

Pin to quick picksSareum Regulatory News (SAR)

Sareum Information

Share Price Information for Sareum (SAR)

Share Price is delayed by 15 minutes
Get Live Data
22.50    1.00 (4.65%)
Bid:
22.00
Ask:
23.00
Spread: 1.00 (4.545%)
Market Cap: £31.18m
SAR Live PriceLast checked at - London Stock Exchange

Intraday Sareum Share Chart

Director/PDMR Shareholding

26 Oct 2007 16:35

Sareum Holdings PLC26 October 2007 Sareum Holdings plcDirector's Shareholding Sareum Holdings plc (the "Company") announces that a director of the Company,Giorgio Reggiani, has purchased an additional 44,444 ordinary shares of 0.025pof the Company (the "Ordinary Shares") at a price of 0.9p per Ordinary Share inthe placing as announced by the Company on 22 October 2007 (the "Placing"). Thispurchase is in addition to the 555,556 Ordinary Shares he originally bought inthe Placing. Following this share purchase, Giorgio Reggiani holds 600,000 Ordinary Sharesrepresenting 0.1 per cent. of the Company's current issued share capital. 26 October 2007 This information is provided by RNS The company news service from the London Stock Exchange
12345678910
Date   Source Headline
1st May 20267:00 amRNSExercise of Warrants
12th Mar 20267:00 amRNSHalf-Year Report for Six Months Ended 31 Dec 2025
12th Mar 20267:00 amRNSHalf-Year Report for Six Months Ended 31 Dec 2025
3rd Mar 20267:00 amRNSNotice of Results and Investor Presentation
17th Feb 20267:00 amRNSRestart of Phase 2-enabling toxicology programme
23rd Jan 20264:36 pmRNSForm 8.3 - Oxford Biomedica plc
9th Dec 20254:25 pmRNSResults of AGM
9th Dec 20257:00 amRNSAnnual General Meeting Statement
17th Nov 20257:00 amRNSNotice of AGM, Annual Report and Accounts
30th Oct 20257:00 amRNSAppointment of Joint Corporate Broker
23rd Oct 20257:00 amRNSPreliminary Results for Year Ended 30 June 2025
10th Oct 20257:00 amRNSUpdate on toxicology study for SDC-1801
7th Oct 20257:00 amRNSNotice of Results and Investor Presentation
26th Sep 20253:12 pmRNSExercise of Warrants
18th Sep 202512:59 pmRNSExercise of Warrants
26th Aug 20257:00 amRNSExercise of Warrants
20th Aug 202510:01 amRNSExercise of Warrants
12th Aug 20257:00 amRNSSareum Collaboration with Receptor.AI
9th Jul 20257:00 amRNSExercise of Warrants
4th Jul 20257:00 amRNSAppointment of Sole Broker
29th May 20257:00 amRNSInitiation of Toxicology Studies for SDC-1801
28th Apr 20257:00 amRNSUpdate on TYK2/JAK1 and SRA737 Programmes
24th Apr 20257:00 amRNSExercise of Warrants
27th Mar 20257:00 amRNSDirector’s Dealing
25th Mar 20257:00 amRNSSareum Half-Year Report
20th Mar 20257:00 amRNSNotice of HY Results and Investor Presentation
13th Mar 20257:15 amRNSInstitutional Equity Fundraise
13th Mar 20257:08 amRNSSareum Acquires Licence for SRA737
31st Dec 20247:00 amRNSUpdate on SRA737
19th Dec 20244:07 pmRNSResults of AGM
19th Dec 20247:00 amRNSAGM Statement
18th Dec 20247:00 amRNSAppointment of Joint Broker
17th Dec 20249:14 amRNSHolding(s) in Company
16th Dec 20247:00 amRNSAward of Share Options
27th Nov 20249:38 amRNSNotice of AGM, Annual Report and Accounts
29th Oct 20247:00 amRNSFinal Results for the Year Ended 30 June 2024
23rd Oct 20247:00 amRNSNotice of Final Results and Investor Presentation
21st Oct 20247:00 amRNSFurther Subscription to raise £1,000,000
11th Oct 20247:00 amRNSSubscription to raise £2,364,000
16th Sep 20247:00 amRNSPatent Allowance in China
2nd Sep 20247:00 amRNSUS patent allowance
10th Jul 20247:00 amRNSManagement Changes
1st Jul 20247:00 amRNSPositive Data from SDC-1801 Phase 1 Clinical Trial
30th May 20247:00 amRNSAppointment of Sole Broker
7th May 20242:10 pmRNSExercise of Warrants
23rd Apr 20247:00 amRNSFinal Issue of RiverFort Subscription Shares
19th Apr 202411:35 amRNSIssue of RiverFort Subscription Shares
15th Apr 20243:28 pmRNSIssue of RiverFort Subscription Shares
9th Apr 20244:00 pmRNSIssue of RiverFort Subscription Shares
4th Apr 20242:38 pmRNSCompletion of Equity Fundraise
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
SPSC
Spectra (di/ S)
LSE
0.00%
BIOG
Biotech Gwth
LSE
-2.38%
SAR
Sareum
LSE
4.65%
EKF
Ekf Diagnostics
LSE
-0.38%
MRL
Marlowe
LSE
0.00%
Trending
BSFA
Bio-Sustainable Future Enterprises
LSE
-20.00%
ITM
Itm Power
LSE
-4.99%
RRR
Red Rock Resources
LSE
15.91%
MKA
Mkango Resources
LSE
-4.52%
QHE
Quantum Helium
LSE
-6.54%